国际皮肤性病学杂志    2006 32 (1): 26-29   ISSN: 2096-5540  CN: 32-1880/R   银屑病与免疫分子调控网络 田晗, 郑捷 上海第二医科大学附属瑞金医院皮肤科, 200025 收稿日期 2005-05-06  修回日期 null  网络版发布日期 null 参考文献  [1] Friedrich M,Krammig S,Henze M,ct al.Flow cytometric characterization of lesional T cells in psoriasis:intracellular cytokine and surface antigen expression indicates an activated,memory/effector type 1 immunophenotype.Arch Dermatol Res,2000,292:519-521. [2] Ovigne JM,Baker BS,Brown DW,et al.Epidermal CD8+ T cells in chronic plaque psoriasis are Tcl cells producing heterogeneous levels of interferon-gamma.Exp Dermatol,2001,10:168-174. [3] Szegedi A,Aleksza M,Gonda A,et al.Elevated rate of Thelperl (T(H) 1) lymphocytes and serum IFN-gamma levels in psoriatic patients.Immunol Lett,2003,86:277-280. [4] Ghoreschi K,Rocken M.Immune deviation strategies in the therapy of psoriasis.Curr Drug Targets Inflamm Allergy,2004,3:193-198. [5] Ghoreschi K,Thomas P,Breit S,et al.Interleukin-4 therapy of psoriasis induces Th2 responses and improves human autoimmune disease.Nat Med,2003,9:40-46. [6] Kawamura A,Adachi K,Ishihara S,et al.Correlation between microsatellite instability and metachronous disease recurrence after endoscopic mucosal resection in patients with early stage gastric carcinoma.Cancer,2001,91:339-345. [7] Wittmann M,Purwar R,Hartmann C,et al.Human keratinocytes respond to interleukin-18:implication for the course of chronic inflammatory skin diseases.J Invest Dermatol,2005,124:1225-1233. [8] Bozza M,Bliss JL,Dorner AJ,et al.Interleukin-11 modulates Th1/Th2 cytokine production from activated CD4+ T cells.J Interferon Cytokine Res,2001,21:21-30. [9] Albanesi C,Scarponi C,Cavani A,et al.Interleukin-17 is produced by both Th1 and Th2 lymphocytes,and modulates interferon-gamma-and interleukin-4-induced activation of human keratinocytes.J Invest Dermatol,2000,115:81-87. [10] Trepicchio WL,Ozawa M,Walters IB,et al.Interleukin-11 therapy selectively downregulates type I cytokine proinflammatory pathways in psoriasis lesions.J Clin Invest,1999,104:1527-1537. [11] Liao YC,Liang WG,Chen FW,et al.IL-19 induces production of IL-6 and TNF-alpha and results in cell apoptosis through TNF-alpha.J Immunol,2002,169:4288-4297. [12] Victor FC,Gottlieb AB.TNF-alpha and apoptosis:implications for the pathogenesis and treatment of psoriasis.J Drugs Dermatol,2002,1:264-275. [13] Johansen C,Flindt E,Kragballe K,et al.Inverse regulation of the nuclear factor-kappaB binding to the p53 and interleukin-8 kappaB response elements in lesional psoriatic skin.J Invest Dermatol,2005,124:1284-1292. [14] Schon MP,Zollner TM,Boehncke WH.The molecular basis of lymphocyte recruitment to the skin:clues for pathogenesis and selective therapies of inflammatory disorders.J Invest Dermatol,2003,121:951-962. [15] Hafezi-Moghadam A,Thomas KL,Prorock AJ,et al.L-selectin shedding regulates leukocyte recruitment.J Exp Med,2001,193:863-872. [16] Singbartl K,Thatte J,Smith ML,et al.A CD2-green fluorescence protein-transgenic mouse reveals very late antigen-4-dependent CD8+ lymphocyte rolling in inflamed venules.J Immunol,2001,166:7520-7526. [17] Jiang WY,Chattedee AD,Raychaudhuri SP,et al.Mast cell density and IL-8 expression in nonlesional and lesional psoriatic skin.Int J Dermatol,2001,40:699-703. [18] Duan H,Koga T,Kohda F,et al.Interleukin-8-positive neutrophils in psoriasis.J Dermatol Sci,2001,26:119-124. [19] Homey B,Dieu-Nosjean MC,Wiesenborn A,et al.Up-regulation of macrophage inflammatory protein-3 alpha/CCL20 and CC chemokine receptor 6 in psoriasis.J Immunol,2000,164:6621. [20] Kakinuma T,Saeki H,Tsunemi Y,et al.Increased serum cutaneous T cell-attracting chemokine (CCL27) levels in patients with atopic dermatitis and psoriasis vulgaris.J Allergy Clin Immunol,2003,111:592-597. [21] Vestergaard C,Johansen C,Otkjaer K,et al.Tumor necrosis factoralpha-induced CTACK/CCL27 (cutaneous T-cell-attracting chemokine) production in keratinocytes is controlled by nuclear factor kappaB.Cytokine,2005,29:49-55. 通讯作者: